Giuseppe Curigliano

Giuseppe Curigliano has most recently been quoted in an article called Novartis challenges Pfizer with strong breast cancer drug data. Giuseppe Curigliano said, “The addition of ribociclib to letrozole does increase the rate of toxicity, but overall, if we evaluate the magnitude of clinical benefit, there is definitely a benefit to be gained from adding ribociclib.”.

Giuseppe Curigliano quotes

Automatically powered by

The addition of ribociclib to letrozole does increase the rate of toxicity, but overall, if we evaluate the magnitude of clinical benefit, there is definitely a benefit to be gained from adding ribociclib.

No quotes...
More Giuseppe Curigliano quotes
|< <
{{currentQuotePage}}/{{numberPage}}
> >|